Related Experiment Video
Updated: Oct 17, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Mortality risk factors among hospitalized children with severe pertussis
Tingting Shi1, Ling Wang2, Shuling Du3
1Department of Respiratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, No.9, Jinsui Road, Zhujiang New City, Tianhe District, Guangzhou, 510120, Guangdong, China.
Insights
Severe pertussis is a significant threat to infants, with high mortality rates in those under six weeks old. High white blood cell counts and pulmonary hypertension are key risk factors for death in severe pertussis cases.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Severe pertussis poses a critical threat to hospitalized infants, often necessitating intensive care.
- Mortality in severe pertussis can result from disease progression or complications.
Purpose of the Study:
- To identify mortality risk factors in children hospitalized with severe pertussis.
- To inform potential adjustments in infant immunization schedules.
Main Methods:
- Retrospective analysis of medical records for 144 hospitalized children with severe pertussis.
- Data collected from Guangzhou Women and Children's Medical Centre (January 2016 - December 2019).
Main Results:
- The majority of severe pertussis cases (90.3%) occurred in infants under six months old.
- Overall mortality was 34.2%, with 76.9% of deaths in infants younger than six weeks.
- Independent risk factors for mortality included a white blood cell count >70.0 × 10^9/L and pulmonary hypertension.
Conclusions:
- Severe pertussis predominantly affects infants under three months old, with a high mortality rate (34.2%).
- Infants under six weeks are particularly vulnerable, accounting for most deaths.
- Recommendations include advancing the first diphtheria-tetanus-pertussis (DTP) vaccine dose to two months or even six weeks of age.
Background:
Some children hospitalized for severe pertussis need intensive care; moreover, some children die because of deterioration alone or in combination with other complications. The purpose of this study was to identify the mortality risk factors among hospitalized children with severe pertussis.
Methods:
This study evaluated the medical records of 144 hospitalized children with severe pertussis at the Guangzhou Women and Children's Medical Centre between January 2016 and December 2019.
Results:
The median age of patients was 2 months (IQR 1-4 months), with 90.3% of the patients aged < 6 months and 56.9% of the patients aged < 3 months. A total of 38 patients were admitted to intensive care unit (ICU), 13 patients died, and the mortality of severe pertussis was 34.2%, with patients younger than 6 weeks accounting for 76.9% of the deaths. On the multivariate analysis, the independent risk factors for death were WBC > 70.0 × 109/L (odds ratio [OR], 230.66; 95% confidence interval [CI], 5.16-10,319.09 P = 0.005) and pulmonary hypertension (PH) (OR 323.29; 95% CI 16.01-6529.42; P < 0.001).
Conclusion:
Severe pertussis mainly occurred in children aged < 3 months. The mortality of severe pertussis was 34.2%, with patients younger than 6 weeks accounting for the majority of the deaths. We recommend the first dose of diphtheria-tetanus-pertussis (DTP) should be advanced to the age of 2 months or even 6 weeks. The presence of a WBC > 70.0 × 109/L and PH were the prognostic independent variables associated with death.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pulmonary Cycle: Exhalation
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia II: Pathophysiology